Home › Overweight › Florida › Pembroke Pines
Overweight clinical trials in Pembroke Pines, FL
6 studies for Overweight are looking for participants at sites in and around Pembroke Pines (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecruitingPhase 3
- Center for Diabetes, Obesity and Metabolism Inc, Pembroke Pines
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- American Research Centers of Florida, Pembroke Pines
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- American Research Centers of Florida, Pembroke Pines
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RecruitingPhase 3
- Center for Diabetes, Obesity and Metabolism Inc, Pembroke Pines
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RecruitingPhase 3Healthy volunteers welcome
- ACCOMPLISH-2 Research Site, Pembroke Pines
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
RecruitingPhase 1
- Center for Diab,Obes & Metab, Pembroke Pines
Overweight trials in other cities
- Houston, TX33 studies
- San Antonio, TX33 studies
- Chicago, IL28 studies
- Orlando, FL25 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Dallas, TX20 studies
- Atlanta, GA20 studies
- Washington, DC19 studies
- Jacksonville, FL19 studies
- New York City, NY19 studies
- Austin, TX18 studies
Other studies in Pembroke Pines
- Non-Small Cell Lung Cancer8 studies
- Obesity8 studies
- Type 2 Diabetes6 studies
- Acute Myeloid Leukemia5 studies
- Lung Cancer5 studies
- Multiple Myeloma3 studies
- Kidney Diseases3 studies
- High Blood Pressure3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.